Is Enzyme Finance Safe?
Risk Grade: B- (28/100)
Enzyme Finance is rated as moderate risk — some novel mechanisms, generally well-understood.
Moderate risk — one of DeFi's most mature asset management platforms with 8+ years of operation and rigorous audits, balanced by composability risk from external DeFi integrations.
Enzyme Finance is one of the oldest on-chain asset management platforms in DeFi, operating since 2017 (originally as Melon Protocol). It enables non-custodial vault creation where managers allocate capital across integrated DeFi protocols with configurable policies and risk controls. With $90M in TVL, 1000+ vaults, and rigorous audit history including PWC audits, its B grade reflects a mature, well-documented design with low mechanism novelty, offset by inherent composability risk from numerous DeFi integrations.
TVL
$82M
Mechanisms
5
Interactions
4
Value Grade
D+
Key Risks for Enzyme Finance Users
Enzyme vaults connect to many external DeFi protocols (Aave, Compound, Uniswap, etc.). A security exploit in any integrated protocol could directly impact Enzyme vaults holding positions in that protocol, though each vault's exposure is limited to the protocols it uses.
Vault managers have discretion over investment decisions within their vault's policy constraints. Poor management decisions or manager malfeasance could result in losses for vault depositors, though policy constraints limit the scope of potential abuse.
The Enzyme Council, rather than broad token holder governance, controls protocol upgrades. This centralized governance model means a small group has significant authority over infrastructure holding $90M+ in assets.
The MLN token has limited price appreciation drivers. Protocol fees are modest relative to MLN's market cap, and the buy-and-burn mechanism may not generate sufficient demand to sustain token value.
Top Risk Factors
- •Vault managers have discretion over asset allocation within policy constraints. A vault manager could make poor investment decisions or exploit their position within the bounds of their vault's policies, resulting in losses for depositors who rely on the manager's competence.
- •Enzyme integrates with numerous external DeFi protocols for vault strategies. Vulnerabilities or exploits in any integrated protocol (Aave, Compound, Uniswap, etc.) could propagate to Enzyme vaults holding positions in those protocols.
- •The modular smart contract architecture enables extensive customization of vault policies and integrations. While this provides flexibility, it also increases the attack surface compared to simpler vault designs, as each integration adapter and policy contract represents a potential vulnerability.
- •MLN token is used for protocol fees but has limited governance utility. The Enzyme Council controls protocol upgrades, creating a degree of centralization in protocol governance despite the decentralized vault infrastructure.
Risk Score Breakdown
Enzyme Finance's highest risk area is Vitality Risk (6/10). Here's how each dimension contributes to the overall 28/100 score:
Read the Full Enzyme Finance Risk Report
This protocol has 2 collapse scenarios. 1 high-severity interaction risks identified. See the full mechanism classification, interaction matrix, and deep-dive recommendations.
View Full Report →Considering an investment?